Last mentioned: 4d ago
Pomerantz announces class actions
Pomerantz issued press releases notifying investors of filed lawsuits and upcoming lead plaintiff deadlines.
Verra Mobility contract termination disclosure
Received Avis Budget Group termination notice effective Sep 2026; revised 2026 outlook downward; cost cuts planned. Stock crashed 70.57% to $3.85 on May 27.
GeneDx Q1 2026 results
Adjusted gross margin 74%→69%, FY revenue guide cut to $475–$490M from $540–$555M, and $31.3M impairment on Fabric Genomics. Stock drop implied.
Badger Meter Q1 2026 results
EPS of $0.93 missed by $0.26, revenue of $202.03M missed by $28.58M; utility water sales -10% YoY. Stock fell 24.13% to $115.54.
PicS Q4/FY 2025 results
Enhanced ECL calculation reclassified R$590M loans to Stage 3, causing R$88M ($17.56M) ECL increase. Stock fell 22.5% to $12.27.
PicS N.V. initial public offering
PicS sold approx. 22.9M shares at $19.00 per share on NASDAQ.
Helen of Troy Q2 2026 results
Quarterly sales down 8.9% YoY, adjusted EPS down 51%, with ongoing disruption warnings. Stock fell 25%.
Helen of Troy Q1 2026 results
Net sales down 11% YoY, adjusted EPS down nearly 60%, and $414.4M goodwill impairment. Stock fell nearly 23%.
GeneDx announces acquisition of Fabric Genomics
GeneDx agreed to acquire Fabric Genomics, an AI-driven genomic interpretation firm.
Helen of Troy Q1 2025 results
Reported 49% YoY decline in EPS and cut full-year revenue outlook by >20%. Stock fell nearly 28%.
Pomerantz LLP has filed suits against five public companies, alleging securities fraud following dramatic stock declines. With lead plaintiff deadlines in early August 2026, investors must act quickly to recover losses. The cases spotlight disclosure lapses in industries from consumer goods to biotech.
This page surfaces every story mentioning Fabric Genomics across our legal coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running legal beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Fabric Genomics was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |